Projected Income Statement: IBM

Forecast Balance Sheet: IBM

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 44,147 42,108 43,085 40,168 46,789 43,313 33,564 28,440
Change - -4.62% 2.32% -6.77% 16.48% -7.43% -22.51% -15.27%
Announcement Date 1/24/22 1/25/23 1/24/24 1/29/25 1/28/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: IBM

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 2,381 1,860 1,488 1,127 1,617 1,556 1,687 1,733
Change - -21.88% -20% -24.26% 43.48% -3.77% 8.41% 2.72%
Free Cash Flow (FCF) 1 6,508 9,291 11,210 12,749 14,734 15,562 16,994 17,786
Change - 42.76% 20.65% 13.73% 15.57% 5.62% 9.2% 4.66%
Announcement Date 1/24/22 1/25/23 1/24/24 1/29/25 1/28/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: IBM

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) - 24.35% 24.97% 26.13% 28.43% 28.75% 29.44% 29.42%
EBIT Margin (%) - 16.42% 17.87% 17.95% 20.92% 21.29% 21.92% 23.02%
EBT Margin (%) 8.43% 1.91% 14.05% 9.24% 15.29% 15.68% 17.95% 19.64%
Net margin (%) 10.01% 2.71% 12.13% 9.6% 15.69% 13.93% 15.58% 16.28%
FCF margin (%) 11.35% 15.35% 18.12% 20.32% 21.82% 22.12% 23.15% 22.98%
FCF / Net Income (%) 113.32% 566.87% 149.43% 211.67% 139.09% 158.81% 148.56% 141.14%

Profitability

        
ROA 3.99% 6.42% 5.73% 7.11% 7.61% 7.6% 7.49% 8.02%
ROE 36.33% 40.77% 33.79% 38.86% 36.67% 32.66% 30.71% 27.66%

Financial Health

        
Leverage (Debt/EBITDA) - 2.86x 2.79x 2.45x 2.44x 2.14x 1.55x 1.25x
Debt / Free cash flow 6.78x 4.53x 3.84x 3.15x 3.18x 2.78x 1.97x 1.6x

Capital Intensity

        
CAPEX / Current Assets (%) 4.15% 3.07% 2.41% 1.8% 2.39% 2.21% 2.3% 2.24%
CAPEX / EBITDA (%) - 12.62% 9.63% 6.87% 8.42% 7.69% 7.81% 7.61%
CAPEX / FCF (%) 36.59% 20.02% 13.27% 8.84% 10.97% 10% 9.93% 9.74%

Items per share

        
Cash flow per share 1 14.15 11.44 15.11 14.35 13.91 18.24 18 18.83
Change - -19.14% 32.08% -5.04% -3.06% 31.14% -1.32% 4.63%
Dividend per Share 1 6.55 6.52 6.63 6.67 6.71 6.765 6.795 6.871
Change - -0.46% 1.69% 0.6% 0.6% 0.82% 0.43% 1.12%
Book Value Per Share 1 21.09 24.31 24.63 29.48 34.84 40.87 47.46 55.15
Change - 15.24% 1.3% 19.71% 18.2% 17.3% 16.11% 16.22%
EPS 1 6.35 1.8 8.14 6.43 11.17 10.12 11.36 12.78
Change - -71.65% 352.22% -21.01% 73.72% -9.37% 12.18% 12.57%
Nbr of stocks (in thousands) 896,800 904,126 913,119 924,645 934,735 942,134 942,134 942,134
Announcement Date 1/24/22 1/25/23 1/24/24 1/29/25 1/28/26 - - -
1USD
Estimates
2026 *2027 *
P/E 21.2x 18.9x
PBR 5.24x 4.51x
EV / Sales 3.48x 3.21x
Yield 3.16% 3.17%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
206.65USD
Average target price
245.33USD
Spread / Average Target
+18.72%

Quarterly revenue - Rate of surprise